List of works - Ted Ross

2018 ISV Congress: advances in the 100 years since the world's deadliest pandemic

scientific article published on 01 January 2019

A Universal Dengue Vaccine Elicits Neutralizing Antibodies Against Strains from All Four Dengue Serotypes

scientific article published on 18 November 2020

A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains

scientific article published on 21 March 2019

A novel nonhuman primate model for influenza transmission

scientific article (publication date: 2013)

A novel outbred mouse model of 2009 pandemic influenza and bacterial co-infection severity.

scientific article

An Influenza Virus Hemagglutinin Computationally Optimized Broadly Reactive Antigen Elicits Antibodies Endowed with Group 1 Heterosubtypic Breadth against Swine Influenza Viruses

scientific article published on 31 March 2020

Are plasma mineral levels related to antibody response to influenza vaccination in older adults?

scientific article published on 11 January 2016

C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cells

scientific article

C3d regulates immune checkpoint blockade and enhances antitumor immunity

scientific article

Challenges and future in vaccines, drug development, and immunomodulatory therapy

scientific article

Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades.

scientific article

Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges

scientific article published on 28 October 2020

Computationally optimized broadly reactive vaccine based upon swine H1N1 influenza hemagglutinin sequences protects against both swine and human isolated viruses

scientific article published on 01 January 2019

Convergent antibody evolution and clonotype expansion following influenza virus vaccination

scientific article published on 22 February 2021

Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design.

scientific article

Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine

scientific article published on 18 November 2014

Dataset of antigenic distance measures, hemagglutination inhibition, viral lung titers, and weight loss in mice and ferrets when exposed to HA-based vaccination or sub-lethal A(H1) influenza infection

scientific article published on 02 August 2020

Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology

scientific article published on 24 May 2016

Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses.

scientific article

Development of a Zika vaccine

scientific article

Elicitation of protective antibodies against a broad panel of H1N1 viruses in ferrets pre-immune to historical H1N1 influenza viruses

scientific article published on 4 October 2017

Eliciting broadly protective antibody responses against influenza

scientific article

Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus

scientific article

Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant

scientific article

Expression and Purification of Virus-like Particles for Vaccination

scientific article published on 2 June 2016

Generation of Monoclonal Antibodies against Immunoglobulin Proteins of the Domestic Ferret (Mustela putorius furo).

scientific article published on 14 February 2017

Glycomic analysis of host response reveals high mannose as a key mediator of influenza severity

scientific article published on 12 October 2020

H1N1, but not H3N2, influenza A virus infection protects ferrets from H5N1 encephalitis.

scientific article

H2 influenza viruses: designing vaccines against future H2 pandemics

scientific article published on 15 January 2019

H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine.

scientific article

Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of viruses

scientific article published on 14 November 2019

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection

scientific article published on 28 December 2020

Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season

scientific article published on 25 June 2015

Immune history shapes specificity of pandemic H1N1 influenza antibody responses.

scientific article

Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice

scientific article

Impact of age and pre-existing immunity on the induction of human antibody responses against influenza B viruses

scientific article published on 08 August 2019

Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains

scientific article published in November 2017

Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age.

scientific article published on 10 March 2014

Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance

scientific article

Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models.

scientific article

Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design.

scientific article

Massive mobilization of dendritic cells during influenza A virus subtype H5N1 infection of nonhuman primates

scientific article

Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

scientific article

Mucosal pre-exposure to Th17-inducing adjuvants exacerbates pathology after influenza infection

scientific article

Portrait of Dr. Ted M. Ross

scientific article

Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season

scientific article

Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination

scientific article published on 16 January 2020

Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities

scientific article

Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists

scientific article published on 27 May 2015

Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies

scientific article

Sex disparities in influenza: A multiscale network analysis

scientific article published on 01 April 2022

Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses

scientific article published in PLoS ONE

Structural and antigenic characterization of a computationally-optimized H5 hemagglutinin influenza vaccine

scientific article published on 31 August 2019

T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response

scholarly article by Leonard Moise et al published 17 July 2018 in Human Vaccines & Immunotherapeutics

Towards a universal influenza vaccine: different approaches for one goal

scientific article published on 19 January 2018

Use of computational and recombinant technologies for developing novel influenza vaccines

scientific article published on 23 November 2015

Vaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice

scientific article published on 26 April 2019

List of works by Ted Ross

2018 ISV Congress: advances in the 100 years since the world's deadliest pandemic

A Universal Dengue Vaccine Elicits Neutralizing Antibodies Against Strains from All Four Dengue Serotypes

A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains

A novel nonhuman primate model for influenza transmission

A novel outbred mouse model of 2009 pandemic influenza and bacterial co-infection severity.

An Influenza Virus Hemagglutinin Computationally Optimized Broadly Reactive Antigen Elicits Antibodies Endowed with Group 1 Heterosubtypic Breadth against Swine Influenza Viruses

Are plasma mineral levels related to antibody response to influenza vaccination in older adults?

C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cells

C3d regulates immune checkpoint blockade and enhances antitumor immunity

Challenges and future in vaccines, drug development, and immunomodulatory therapy

Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades.

Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges

Computationally optimized broadly reactive vaccine based upon swine H1N1 influenza hemagglutinin sequences protects against both swine and human isolated viruses

Convergent antibody evolution and clonotype expansion following influenza virus vaccination

Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design.

Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine

Dataset of antigenic distance measures, hemagglutination inhibition, viral lung titers, and weight loss in mice and ferrets when exposed to HA-based vaccination or sub-lethal A(H1) influenza infection

Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology

Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses.

Development of a Zika vaccine

Elicitation of protective antibodies against a broad panel of H1N1 viruses in ferrets pre-immune to historical H1N1 influenza viruses

Eliciting broadly protective antibody responses against influenza

Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus

Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant

Expression and Purification of Virus-like Particles for Vaccination

Generation of Monoclonal Antibodies against Immunoglobulin Proteins of the Domestic Ferret (Mustela putorius furo).

Glycomic analysis of host response reveals high mannose as a key mediator of influenza severity

H1N1, but not H3N2, influenza A virus infection protects ferrets from H5N1 encephalitis.

H2 influenza viruses: designing vaccines against future H2 pandemics

H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine.

Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of viruses

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection

Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season

Immune history shapes specificity of pandemic H1N1 influenza antibody responses.

Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice

Impact of age and pre-existing immunity on the induction of human antibody responses against influenza B viruses

Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains

Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age.

Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance

Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models.

Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design.

Massive mobilization of dendritic cells during influenza A virus subtype H5N1 infection of nonhuman primates

Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

Mucosal pre-exposure to Th17-inducing adjuvants exacerbates pathology after influenza infection

Portrait of Dr. Ted M. Ross

Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season

Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination

Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities

Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists

Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies

Sex disparities in influenza: A multiscale network analysis

Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses

Structural and antigenic characterization of a computationally-optimized H5 hemagglutinin influenza vaccine

T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response

Towards a universal influenza vaccine: different approaches for one goal

Use of computational and recombinant technologies for developing novel influenza vaccines

Vaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice